Secondary analysis of an RCT of valacyclovir vs placebo in herpes zoster ophthalmicus: recurrent, new or worsening stromal keratitis occurred in 105 of 527 participants (20%), unrelated to randomisation group; vision stayed good and only 10% got open-label antiviral.
Secondary analysisn = 527
Jacobs et al. Stromal Keratitis in the Zoster Eye Disease Study: Lessons Learned